ChAdOx1 COVID vaccines express RBD open prefusion SARS-CoV-2 spikes on the cell surface

Summary: Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been proven to be an effective means of decreasing COVID-19 mortality, hospitalization rates, and transmission. One of the vaccines deployed worldwide is ChAdOx1 nCoV-19, which uses an adenovirus vector to dr...

Full description

Bibliographic Details
Main Authors: Tao Ni, Luiza Mendonça, Yanan Zhu, Andrew Howe, Julika Radecke, Pranav M. Shah, Yuewen Sheng, Anna-Sophia Krebs, Helen M.E. Duyvesteyn, Elizabeth Allen, Teresa Lambe, Cameron Bisset, Alexandra Spencer, Susan Morris, David I. Stuart, Sarah Gilbert, Peijun Zhang
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:iScience
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004223019594